Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tamoxifen citrate

EU orphan designation number: EU/3/17/1877   
Active ingredient: Tamoxifen citrate
Indication: Treatment of cystic fibrosis
Sponsor: GB Pharma Srl
Via Ferreri, 11, 27100 Pavia, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/05/2017 Orphan designation EMA/OD/006/17 (2017)3610 of 22/05/2017